Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: The protein corona at the nano-bio interface: the need for standardized methodology and opportunities for neurodegenerative disease intervention.

RSC advances·2026
Same author

Soluble zinc-induced amyloid β oligomers probed through fluorine NMR spectroscopy.

Communications chemistry·2026
Same author

A multi-stakeholder perspective on barriers to the adoption of personalized prevention in European healthcare systems.

Frontiers in public health·2026
Same author

Smoking prevalence in Italy from 1993 to 2024: a trend analysis framed by public health policies and emerging consumption behaviors.

Journal of public health (Oxford, England)·2026
Same author

Identifying Two New Ros/MucR Proteins: An Atypical Structure with a Divergent Function.

Biomolecules·2026
Same author

Ultrasound Elastography in the Diagnosis and Management of Uterine Pathologies: A Systematic Review.

Journal of clinical medicine·2026

Related Experiment Video

Updated: Jun 8, 2026

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
07:55

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces

Published on: January 7, 2020

Engineering a PD-L1-sensing synthetic receptor for programmable macrophage response.

Ilaria De Martino1,2, Luigi Russo3, Matteo Marchetti1,4

  • 1Istituto Italiano di Tecnologia-IIT, Largo Barsanti e Matteucci, 80125, Naples, Italy.

Journal of Biological Engineering
|June 6, 2026
PubMed
Summary

Scientists engineered a synthetic receptor (SNIPR) to detect programmed death-ligand 1 (PD-L1). This allows engineered cells to activate phagocytosis, enhancing cancer cell engulfment and offering a new way to control immune responses.

More Related Videos

Production and Characterization of Human Macrophages from Pluripotent Stem Cells
08:05

Production and Characterization of Human Macrophages from Pluripotent Stem Cells

Published on: April 16, 2020

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays
08:37

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jun 8, 2026

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
07:55

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces

Published on: January 7, 2020

Production and Characterization of Human Macrophages from Pluripotent Stem Cells
08:05

Production and Characterization of Human Macrophages from Pluripotent Stem Cells

Published on: April 16, 2020

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays
08:37

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays

Published on: April 18, 2025

Area of Science:

  • Synthetic biology
  • Immunology
  • Cellular engineering

Background:

  • Cellular decision-making integrates extracellular cues for functional responses.
  • Synthetic biology enables rewiring cellular processes with engineered receptors.
  • Programmed death-ligand 1 (PD-L1) is a key immune-regulatory ligand.

Purpose of the Study:

  • To engineer a synthetic receptor that enables monocytic-like cells to sense PD-L1.
  • To conditionally activate a phagocytic program in response to PD-L1.
  • To establish a modular framework for ligand-responsive control of engineered macrophage behavior.

Main Methods:

  • Engineered a synthetic Notch-based receptor (SNIPR) to detect PD-L1.
  • Programmed SNIPR to trigger outputs like fluorescent reporters or CV1-Fc upon PD-L1 engagement.
  • Utilized THP-1-derived macrophages and SKOV-3 ovarian cancer cells for in vitro experiments.

Main Results:

  • SNIPR activation scaled with PD-L1 levels.
  • The circuit partially attenuated PD-1/PD-L1 signaling.
  • Conditional CV1-Fc expression enhanced macrophage engulfment of cancer cells.

Conclusions:

  • PD-L1 can be repurposed from a therapeutic target to a programmable input signal for synthetic circuits.
  • This work establishes a modular framework for ligand-responsive control of engineered macrophage behavior.
  • The engineered system offers a novel approach for modulating immune responses in cellular therapies.